Skip to main content
NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDZAR-0.17%USDILS+0.16%EURCAD+0.16%EURJPY+0.13%SGDJPY+0.13%USDTHB-0.11%EURGBP+0.11%NZDCAD+0.10%USDTRY+0.10%NZDJPY+0.09%AUDCAD+0.08%EURUSD+0.08%AUDJPY+0.07%USDSGD-0.07%EURCHF+0.07%AUDSGD-0.07%GBPSGD-0.07%GBPNZD-0.07%USDCAD+0.07%CHFSGD-0.06%NZDCHF+0.06%CADCHF-0.06%NZDSGD-0.05%EURAUD+0.05%CHFJPY+0.05%GBPAUD-0.05%NZDUSD+0.05%AUDCHF+0.04%USDJPY+0.04%USDCOP-0.04%GBPCHF-0.03%USDCNH+0.03%NZDMXN+0.03%AUDNZD-0.03%AUDUSD+0.03%GBPUSD-0.02%GBPCAD+0.02%EURSGD+0.01%EURNZD+0.01%GBPJPY+0.01%USDHKD+0.01%CADJPY-0.01%USDCHF0.00%USDMXN0.00%USDPLN0.00%USDDKK0.00%EURNOK0.00%USDSEK0.00%EURPLN0.00%EURHKD0.00%PLNJPY0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSEK0.00%AUDDKK0.00%CHFSEK0.00%EURDKK0.00%GBPZAR0.00%NOKJPY0.00%CHFNOK0.00%EURCZK0.00%USDNOK0.00%XNGUSD-1.55%USOIL-1.45%GAGUSD+0.49%XAGUSD+0.49%XPTUSD+0.38%HG1+0.24%GAUUSD+0.03%XAUUSD+0.03%W10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.35%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.52%ZECUSDT+0.68%DOGEUSD+20.76%XMRUSDT-3.47%LINKUSD+23.15%BCHUSDT+0.92%XLMUSD-1.68%UNIUSD+1.99%LTCUSD+17.32%SUIUSD-1.75%HBARUSDT-0.67%TONUSD+36.45%TAOUSDT+0.91%AAVEUSD-0.56%DOTUSDT-1.53%ICPUSDT-1.44%ONDOUSDT-0.79%WLDUSDT-3.10%ARBUSDT+0.48%JUPUSDT-2.64%ATOMUSDT+0.17%INJUSDT+2.67%STXUSDT+0.23%TIAUSDT-0.56%PYTHUSDT+6.10%FETUSDT-1.86%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.80%OPUSDT-1.73%IOTAUSDT-1.85%WIFUSDT-3.57%POLUSDT+0.01%AXSUSDT-2.01%EOSUSDT-3.66%FARTCOINUSDT-2.46%DYDXUSDT-2.81%GALAUSDT-2.36%ORDIUSDT-1.64%RONINUSDT-1.68%NOTUSDT-2.67%NVDA+0.10%AAPL-0.10%GOOGL-1.24%MSFT0.00%AMZN+0.25%TSM+1.49%SPCX+1.89%META-0.36%AVGO-0.48%TSLA-0.14%LLY-2.54%BRK-B-0.87%MU+0.09%SKHY+4.05%WMT-1.02%JPM-1.47%AMD+1.74%V-1.55%XOM+2.79%JNJ-1.42%ASMLa-0.87%MA-1.52%ABBV+0.16%CVX+2.88%INTC+1.72%0700.HK+0.94%COST-1.46%1398.HK-1.50%CSCO+1.53%KO-2.76%ORCL+0.49%UNH-1.62%PG-2.76%BAC-1.02%1816.HK+0.44%3988.HK-0.50%HD-2.41%CAT-2.42%0005.HK-1.04%PM-1.13%HSBA.L-1.07%AP2d-0.03%0857.HK-0.93%0939.HK+0.51%AMAT+0.44%GE-2.69%1288.HK-1.94%DELL+0.77%LRCX-0.02%NVS-3.30%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDZAR-0.17%USDILS+0.16%EURCAD+0.16%EURJPY+0.13%SGDJPY+0.13%USDTHB-0.11%EURGBP+0.11%NZDCAD+0.10%USDTRY+0.10%NZDJPY+0.09%AUDCAD+0.08%EURUSD+0.08%AUDJPY+0.07%USDSGD-0.07%EURCHF+0.07%AUDSGD-0.07%GBPSGD-0.07%GBPNZD-0.07%USDCAD+0.07%CHFSGD-0.06%NZDCHF+0.06%CADCHF-0.06%NZDSGD-0.05%EURAUD+0.05%CHFJPY+0.05%GBPAUD-0.05%NZDUSD+0.05%AUDCHF+0.04%USDJPY+0.04%USDCOP-0.04%GBPCHF-0.03%USDCNH+0.03%NZDMXN+0.03%AUDNZD-0.03%AUDUSD+0.03%GBPUSD-0.02%GBPCAD+0.02%EURSGD+0.01%EURNZD+0.01%GBPJPY+0.01%USDHKD+0.01%CADJPY-0.01%USDCHF0.00%USDMXN0.00%USDPLN0.00%USDDKK0.00%EURNOK0.00%USDSEK0.00%EURPLN0.00%EURHKD0.00%PLNJPY0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSEK0.00%AUDDKK0.00%CHFSEK0.00%EURDKK0.00%GBPZAR0.00%NOKJPY0.00%CHFNOK0.00%EURCZK0.00%USDNOK0.00%XNGUSD-1.55%USOIL-1.45%GAGUSD+0.49%XAGUSD+0.49%XPTUSD+0.38%HG1+0.24%GAUUSD+0.03%XAUUSD+0.03%W10.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.35%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.52%ZECUSDT+0.68%DOGEUSD+20.76%XMRUSDT-3.47%LINKUSD+23.15%BCHUSDT+0.92%XLMUSD-1.68%UNIUSD+1.99%LTCUSD+17.32%SUIUSD-1.75%HBARUSDT-0.67%TONUSD+36.45%TAOUSDT+0.91%AAVEUSD-0.56%DOTUSDT-1.53%ICPUSDT-1.44%ONDOUSDT-0.79%WLDUSDT-3.10%ARBUSDT+0.48%JUPUSDT-2.64%ATOMUSDT+0.17%INJUSDT+2.67%STXUSDT+0.23%TIAUSDT-0.56%PYTHUSDT+6.10%FETUSDT-1.86%SEIUSDT-3.15%IMXUSDT-1.05%GRTUSDT-1.80%OPUSDT-1.73%IOTAUSDT-1.85%WIFUSDT-3.57%POLUSDT+0.01%AXSUSDT-2.01%EOSUSDT-3.66%FARTCOINUSDT-2.46%DYDXUSDT-2.81%GALAUSDT-2.36%ORDIUSDT-1.64%RONINUSDT-1.68%NOTUSDT-2.67%
AM

Avita Medical Inc. (RCEL)

NASDAQ • Healthcare

$15.51
+$0.08 (+0.6%)
Market closed

Last close at October 23, 2026 at 20:00 UTC

Open$15.37
Day Range$14.28 - $15.62
Avg. Volume (3M)387.9K
Market Cap$385.3M
52 Week Range
$3.22$15.68
Next EarningsIn 11 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$21.7M100%
Gross Profitminus cost of goods$17.7M82%

In plain terms: out of every $100 in revenue, Avita Medical Inc. currently loses $35.

Fundamentals & Financials

Revenue (TTM)
$75.6M
Net Income (TTM)
-$43M
EPS (TTM)
-$1.45
ROA (TTM)
-90.17%
Current Ratio
0.41

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-4.3%Q1 2026-$0.38
0.0%Q2 2026-$0.35
+14.6%Q3 2026-$0.25
Next

Nov 5

in 11 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +14.6%

Avita Medical beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 6, 2026, with revenue rising 17.8% to about $21.7 million on its RECELL wound-care and skin-restoration platform. On consensus, revenue of $21.7 million topped the $20.2 million estimate, +7%, while EPS of -$0.25 topped the -$0.29 estimate by $0.04, improving from -$0.38 a year ago (+34.2% YoY). Gross profit came in around $17.8 million, with gross margin at about 82%, and operating margin was -31.6% as operating income was roughly -$6.9 million. Net income was about -$7.7 million, narrowing from roughly -$9.9 million a year ago (+22.8% YoY). The company posted negative operating cash flow of around $3.5 million for the quarter. For the next period, consensus calls for EPS of -$0.24 on revenue of $22.4 million.

Next report — what to expect

Avita Medical Inc. (RCEL) reports on November 5, 2026. Consensus calls for EPS of -$0.239 on revenue of $22.4 million. For trailing context, revenue grew +17.8% year over year last quarter. The company has beaten EPS in 1 of 8 most recent quarters, setting a notable watch point versus expectations.

View full earnings history

About Avita Medical Inc.

Avita Medical Inc. develops and sells wound-care and skin-restoration devices on NASDAQ as RCEL, operating in medical devices within healthcare. Its RECELL platform and related matrices are used in hospital and treatment-center settings, and the company generated $71.6 million of revenue in FY2025.

Name
Avita Medical Inc.
CEO
Cary G. Vance
Industry
Healthcare
Employees
226

Today's Snapshot

AI-generated

RCEL closed 0.6% above yesterday's close, outperforming a weaker sector. At the close, RCEL was within 1.1% of its 52-week high of 15.68. RCEL is due to report earnings on 5 November.

Trading Volume

Below 10d avg (441.8K)

395.4K

vs S&P 500 Today

Outperforming Market

+1.10%

Updated: October 23, 2026 at 20:09 UTC

Technical Indicators

6 Buy0 Neutral2 Sell
RCEL shows a strong bullish profile driven by a commanding trend and broad-moving-average support: the ADX is above 50 and the price sits well above short-, medium- and long-term averages, indicating a sustained uptrend. Momentum indicators are mixed — high RSI and Stochastic readings suggest overbought conditions while CCI and MACD register buy signals — and on-balance volume is strongly positive, supporting the advance. Volatility is elevated relative to price, and the pivot is roughly at the current level. Technical takeaway: trend-confirmed strength underpins the strong-buy consensus.
All signals
  • EMA (5 indicators)$7.24 - $14.19
    Buy
  • RSI (14)78.81
    Sell
  • Stochastic %K (14, 3, 3)92.42
    Sell
  • MACD Level (12, 26)1.06
    Buy

Peers & Related Assets

STTKShattuck Labs, Inc.
OVIDOvid Therapeutics Inc.
QIPTQuipt Home Medical Corp.
FONRFonar Corp.
VANIVivani Medical, Inc.
APYXApyx Medical Corporation
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.